| |

Common Drugs May Impact Mesothelioma Survival After Immunotherapy

ByAlex Strauss
Mesothelioma survival after immunotherapy

There is new evidence that taking certain common drugs could negatively impact mesothelioma survival after immunotherapy. 

Drugs such as NSAIDs, antacids, corticosteroids, and antibiotics affect the microbiome. The microbiome is the collection of bacteria that live in a person’s gut. 

The microbiome interacts with the immune system. Ohio State University researchers say some medicines disrupt the microbiome. This can threaten the effectiveness of cancer immunotherapy. 

The Microbiome and Immunity

The microbiome is the collection of bacteria that live in the intestinal tract. Every mesothelioma patient’s microbiome is unique. Scientists are just beginning to understand the importance of the microbiome in human health. 

At first glance, there might not seem to be a direct correlation between the microbiome and mesothelioma survival after immunotherapy. But scientists know that there is a relationship between the microbiome and immunity. 

The aim of the new study was to understand how that relationship might impact cancer immunotherapy. 

The Microbiome Affects Mesothelioma Survival After Immunotherapy

Immunotherapy is a cancer treatment that uses the power of the immune system to fight cancer. It is an important area of mesothelioma research. 

Immune checkpoint inhibitors are one type of immunotherapy. Pembrolizumab (Keytruda) is an example of an ICI. Studies show some patients experience longer mesothelioma survival after immunotherapy with Keytruda. 

But not all mesothelioma patients respond well to ICIs. The new study suggests this could have to do with their microbiome. “There is growing evidence that the microbiome can significantly influence immune checkpoint inhibitor therapy,” says first author Daniel Spakowicz, PhD.

In the study, cancer patients who took medications that disrupted their microbiome had worse outcomes. If the findings are right, it could lead to a microbiome test for cancer patients. The test could help identify patients with the best odds of mesothelioma survival after immunotherapy. 

Timing of Medications is Important

The Ohio State team analyzed data from 690 patients with advanced cancer. The patients received immunotherapy with ICIs between 2011 and 2017. The team made a model showing how some common drugs relate to cancer treatment outcomes. 

They focused on medications known to affect the microbiome. They included 

  • Non-steroidal anti-inflammatory drugs (NSAIDs) like Advil, Motrin and aspirin
  • Histamine blockers (antacids) like Tagamet and Zantac
  • Corticosteroids like prednisone and Celestone
  • Antibiotics like amoxicillin and Cephalexin

The patients who took antibiotics or corticosteroids within 28 days of ICI therapy had reduced survival after immunotherapy. Beta lactam antibiotics like penicillin derivatives had the strongest link to survival.

Antacids and NSAIDs negatively affected survival in specific cancers. The NSAIDs were especially detrimental in people with non-small cell lung cancer. Pleural mesothelioma and non-small cell lung cancer share many similarities. This suggests that NSAIDs might also negatively impact mesothelioma survival after immunotherapy.

Sources:

Spakowicz, D, et al, “Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications”, May 6, 2020, BMC Cancer, https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-06882-6

“Microbiome Might Reveal Whether Immune Therapy Can Benefit a Patient, Study Shows”, July 14, 2020, Ohio State University Comprehensive Cancer Center, https://cancer.osu.edu/news/microbiome-might-reveal-whether-immune-therapy-can-benefit-a-patient-study-shows

Similar Posts

Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers
| |

Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

ByAlex Strauss

Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma
| |

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

ByAlex Strauss

A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

Mesothelioma Still Rising Despite Ban in Ireland
|

Mesothelioma Still Rising Despite Ban in Ireland

ByAlex Strauss

A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

Does Radiotherapy Reduce Mesothelioma Pain?
| |

Does Radiotherapy Reduce Mesothelioma Pain?

ByAlex Strauss

A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

Website Aims to Protect Homeowners from Mesothelioma
|

Website Aims to Protect Homeowners from Mesothelioma

ByAlex Strauss

Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

Ape Virus Shrinks Mesothelioma Tumors in Lab
|

Ape Virus Shrinks Mesothelioma Tumors in Lab

ByAlex Strauss

A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…